MTAP and cancer: Since the majority of MTAP-deleted NPC harbors wild-type p53, the high levels of p53 induction triggered by MAT2A inhibitor may underlie the potent tumor suppressor activity observed in NPC in contrast to other MTAP-deleted but largely TP53-mutated cancers.